Broadfoot Jill Marie
CIK 0001305178
Chief Financial OfficerDirector
Filings
18
Latest Feb 4, 2026
Issuers covered
4
Showing
18 of 18
Page 1
Track record
1 of 6 open-market trades scored (17% price coverage) - 5 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 0% | -0.1% | -0.1% | -0.1% | -0.1% |
| 90 days | 1 | 0% | -60.1% | -60.1% | -60.1% | -60.1% |
| 180 days | - | - | - | - | - | - |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Broadfoot Jill Marie has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| LIFE | Atyr Pharma Inc | 12 | Feb 4, 2026 |
| ACRX | Acelrx Pharmaceuticals Inc | 3 | Oct 24, 2025 |
| CUE | Cue Biopharma, Inc. | 2 | Jan 6, 2026 |
| OTIC | Otonomy, Inc. | 1 | Jun 23, 2022 |
All filings
18 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|